Long-term metabolic fate and mortality in obesity without metabolic syndrome

References

• Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1432–1645.
   Web of Science ®Google Scholar
• Wong MCS, Huang J, Wang J, et al. Global, regional and time-trend prevalence of Central obesity: a systematic review and meta-analysis of 13.2 million subjects. Eur J Epidemiol. 2020;35(7):673–683.
   PubMed Web of Science ®Google Scholar
• Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep. 2018;20(2):12.
   PubMed Web of Science ®Google Scholar
• Kim Y-G, Choi K-J, Han S, et al. Metabolic syndrome and the risk of New-Onset atrial fibrillation in Middle-Aged East Asian men. Circ J Jpn Circ Soc. 2018;82(7):1763–1769.
   PubMed Web of Science ®Google Scholar
• Watanabe H, Tanabe N, Watanabe T, et al. Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation. 2008;117(10):1255–1260.
   PubMed Web of Science ®Google Scholar
• Asad Z, Abbas M, Javed I, et al. Obesity is associated with incident atrial fibrillation independent of gender: a Meta-analysis. J Cardiovasc Electrophysiol. 2018;29(5):725–732.
   PubMed Web of Science ®Google Scholar
• Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and Meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–1132.
   PubMed Web of Science ®Google Scholar
• Riaz H, Khan MS, Siddiqi TJ, et al. Association between obesity and cardiovascular outcomes: a systematic review and Meta-analysis of Mendelian randomization studies. JAMA Netw Open. 2018;1(7):e183788.
   PubMed Web of Science ®Google Scholar
• Di Angelantonio E, Bhupathiraju SN, Wormser D, et al. Body-mass index and all-cause mortality: individual-participant-data Meta-analysis of 239 prospective studies in four continents. Lancet Lond Engl. 2016;388(10046):776–786.
   PubMed Web of Science ®Google Scholar
• Wu SH, Hui WS, Liu Z, et al. Metabolic syndrome and all-cause mortality: a Meta-analysis of prospective cohort studies. Eur J Epidemiol. 2010;25(6):375–384.
   PubMed Web of Science ®Google Scholar
• Lin H, Zhang L, Zheng R, et al. The prevalence, metabolic risk and effects of lifestyle intervention for metabolically healthy obesity: a systematic review and Meta-analysis: a PRISMA-compliant article. Medicine (Baltimore). 2017;96(47):e8838.
   PubMed Web of Science ®Google Scholar
• Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Invest. 2019;129(10):3978–3989.
   PubMed Web of Science ®Google Scholar
• Iacobini C, Pugliese G, Blasetti Fantauzzi C, et al. Metabolically healthy versus metabolically unhealthy obesity. Metabolism. 2019;92:51–60.
   PubMed Web of Science ®Google Scholar
• Ortega FB, Cadenas-Sanchez C, Migueles JH, et al. Role of physical activity and fitness in the characterization and prognosis of the metabolically healthy obesity phenotype: a systematic review and Meta-analysis. Prog Cardiovasc Dis. 2018;61(2):190–205.
   PubMed Web of Science ®Google Scholar
• Goday A, Calvo E, Vázquez LA, et al. Prevalence and clinical characteristics of metabolically healthy obese individuals and other obese/non-obese metabolic phenotypes in a working population: results from the Icaria study. BMC Public Health. 2016;16:248.
   PubMed Web of Science ®Google Scholar
• Echouffo-Tcheugui JB, Short MI, Xanthakis V, et al. Natural history of obesity subphenotypes: dynamic changes over two decades and prognosis in the Framingham heart study. J Clin Endocrinol Metab. 2019;104(3):738–752.
   PubMed Web of Science ®Google Scholar
• Bell JA, Hamer M, Sabia S, et al. The natural course of healthy obesity over 20 years. J Am Coll Cardiol. 2015;65(1):101–102.
   PubMed Web of Science ®Google Scholar
• Mongraw-Chaffin M, Foster MC, Anderson CAM, et al. Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol. 2018;71(17):1857–1865.
   PubMed Web of Science ®Google Scholar
• Kouvari M, Panagiotakos DB, Yannakoulia M, et al. Transition from metabolically benign to metabolically unhealthy obesity and 10-year cardiovascular disease incidence: the ATTICA cohort study. Metabolism. 2019;93:18–24.
   PubMed Web of Science ®Google Scholar
• Hamer M, Bell JA, Sabia S, et al. Stability of metabolically healthy obesity over 8 years: the English longitudinal study of ageing. Eur J Endocrinol. 2015;173(5):703–708.
   PubMed Web of Science ®Google Scholar
• Nyström PK, Carlsson AC, Leander K, et al. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PLoS One. 2015;10(5):e0127111.
   PubMed Web of Science ®Google Scholar
• Feng T, Vegard M, Strand LB, et al. Metabolically healthy obesity and risk for atrial fibrillation: the HUNT study. Obesity (Silver Spring). 2019;27(2):332–338.
   PubMed Web of Science ®Google Scholar
• Lee H, Choi EK, Lee SH, et al. Atrial fibrillation risk in metabolically healthy obesity: a nationwide population-based study. Int J Cardiol. 2017;240:221–227.
   PubMed Web of Science ®Google Scholar
• Fauchier G, Bisson A, Bodin A, et al. Metabolically healthy obesity and cardiovascular events: a nationwide cohort study. Diabetes Obes Metab. 2021;23(11):2492–2501.
   PubMed Web of Science ®Google Scholar
• Opio J, Croker E, Odongo GS, et al. Metabolically healthy overweight/obesity are associated with increased risk of cardiovascular disease in adults, even in the absence of metabolic risk factors: a systematic review and meta-analysis of prospective cohort studies. Obes Rev. 2020;21(12):e13127.
   PubMed Web of Science ®Google Scholar
• Rantala AO, Kauma H, Lilja M, et al. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med. 1999;245(2):163–174.
   PubMed Web of Science ®Google Scholar
• Ballestri S, Romagnoli D, Nascimbeni F, et al. Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Rev Gastroenterol Hepatol. 2015;9(5):603–627.
   PubMed Web of Science ®Google Scholar
• Troy BL, Pombo J, Rackley CE. Measurement of left ventricular wall thickness and mass by echocardiography. Circulation. 1972;45(3):602–611.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Macpherson J, Gray SR, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK biobank participants. Diabetologia. 2021;64(9):1963–1972.
   PubMed Web of Science ®Google Scholar
• Caleyachetty R, Thomas GN, Toulis KA, et al. Metabolically healthy obese and incident cardiovascular disease events among 3.5 Million Men and Women. J Am Coll Cardiol. 2017;70(12):1429–1437.
   PubMed Web of Science ®Google Scholar
• Tian Q, Wang A, Zuo Y, et al. All-cause mortality in metabolically healthy individuals was not predicted by overweight and obesity. JCI Insight. 2020;5(16):e136982.
   PubMed Web of Science ®Google Scholar
• Zheng R, Zhou D, Zhu Y. The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and Meta-analysis. J Epidemiol Community Health. 2016;70(10):1024–1031.
   PubMed Web of Science ®Google Scholar
• Ärnlöv J, Ingelsson E, Sundström J, et al. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121(2):230–236.
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet Lond Engl. 2004;363(9403):157–163.
   PubMed Web of Science ®Google Scholar
• Bae YS, Choi S, Lee K, et al. Association of concurrent changes in metabolic health and weight on cardiovascular disease risk: a nationally representative cohort study. J Am Heart Assoc. 2019;8(17):e011825.
   PubMed Web of Science ®Google Scholar
• Gallardo-Escribano C, Vargas-Candela A, Vilches-Perez A, et al. Lifestyle modification improves insulin resistance and carotid Intima-Media thickness in a metabolically healthy obese prepubescent population. J Pediatr Gastroenterol Nutr. 2021;72(1):127–134.
   PubMed Web of Science ®Google Scholar
• Sinn DH, Kang D, Cho SJ, et al. Weight change and development of subclinical carotid atherosclerosis among metabolically healthy adults: a cohort study. J Clin Endocrinol Metab. 2020;105(3):dgz0401.
   Web of Science ®Google Scholar
• Dobson R, Burgess MI, Sprung VS, et al. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity. Int J Obes (Lond). 2016;40(1):153–161.
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA. 2001;285(18):2370–2375.
   PubMed Web of Science ®Google Scholar
• Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001;76(5):467–475.
   PubMed Web of Science ®Google Scholar
• Schoonderwoerd BA, Smit MD, Pen L, et al. New risk factors for atrial fibrillation: causes of” not-so-lone atrial fibrillation”. eur eur pacing arrhythm card electrophysiol J work groups card pacing arrhythm. Europace. 2008;10(6):668–673.
   PubMed Web of Science ®Google Scholar
• Hildrum B, Mykletun A, Hole T, et al. Age-specific prevalence of the metabolic syndrome defined by the international diabetes federation and the national cholesterol education program: the Norwegian HUNT 2 study. BMC Public Health. 2007;7:220.
   PubMed Web of Science ®Google Scholar
• Appleton SL, Seaborn CJ, Visvanathan R, et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care. 2013;36(8):2388–2394.
   PubMed Web of Science ®Google Scholar
• Camhi SM, Must A, Gona PN, et al. Duration and stability of metabolically healthy obesity over 30 years. Int J Obes. 2019;43(9):1803–1810.
   Web of Science ®Google Scholar
• Hwang YC, Hayashi T, Fujimoto WY, et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int J Obes. 2015;39(9):1365–1370.
   PubMed Web of Science ®Google Scholar
• Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham heart study. Circulation. 2007;116(1):39–48.
   PubMed Web of Science ®Google Scholar
• Blüher M. Metabolically healthy obesity. Endocr Rev. 2020;41(3):bnaa004.
   PubMed Web of Science ®Google Scholar
• Kastarinen MJ, Salomaa VV, Vartiainen EA, et al. Trends in blood pressure levels and control of hypertension in Finland from 1982 to 1997. J Hypertens. 1998;16(9):1379–1387.
   PubMed Web of Science ®Google Scholar